SCHEMBL16615538

SCHEMBL16615538

Brc1ccc(C#CC#Cc2cccc(Br)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.41
ALDH1A1 P00352 4/20 0.37
MAPK1 P28482 1/20 0.37
MAOB P27338 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP2A6 P11509 2/20 0.33
PYCR1 P32322 1/20 0.33
APP P05067 1/20 0.33
CA12 O43570 4/20 0.32
CA1 P00915 4/20 0.32
CA2 P00918 4/20 0.32
CA9 Q16790 4/20 0.32
C1S P09871 1/20 0.31
MAOA P21397 1/20 0.31
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29868615 0.91 GRM5 (0.46) GRM5ALDH1A1MAPK1TDP1APP
SCHEMBL26180912 0.82 APP (0.52) GRM5ALDH1A1MAPK1TDP1MEN1
SCHEMBL1375869 0.82 GRM5 (0.53) GRM5ALDH1A1MAPK1TDP1APP
SCHEMBL29779956 0.82 GRM5 (0.53) GRM5ALDH1A1MAPK1TDP1APP
SCHEMBL5012561 0.82 CYP2A6 (0.50) ALDH1A1MAPK1MAOBTDP1MEN1
SCHEMBL8000068 0.80 APP (0.57) GRM5ALDH1A1MAPK1TDP1MEN1
SCHEMBL29825848 0.80 APP (0.57) GRM5ALDH1A1MAPK1TDP1MEN1
SCHEMBL28663424 0.79 GRM5 (0.41) GRM5ALDH1A1MAPK1MEN1KMT2A
SCHEMBL30361092 0.79 GRM5 (0.45) GRM5ALDH1A1MAPK1MAOBNPC1
SCHEMBL15810283 0.78 PYCR1 (0.38) GRM5MAOBCYP1A2PYCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3049506-B1 COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2017-06-14 EP disclosed
US-20160229795-A1 COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2016-08-11 US disclosed
US-20150315470-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2015-11-05 US disclosed
WO-2015043713-A1 COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2015-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229795-A1 COMPOUNDS AND MESOGENIC MEDIA MTX1, NEFM, MTX2 GRM5 2745/4885ALDH1A1 2642/4885MAPK1 424/4885
US-20150315470-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA SP1, FOXM1, S100A11 GRM5 1598/4885ALDH1A1 4654/4885MAPK1 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.